8
mM NaCl, 0.1 mg/ml CaCl 2 and 0.1 mg/ml MgCl 2 6H 2 O) to remove unbound sulfo-NHS-biotin and lysed in lysis buffer B (20 mM Tris-Cl, pH 7.5, 1% Triton X-100, 0.1% SDS, and 1% sodium deoxycholate) containing protease inhibitors. Immobilized monomeric avidin gel (Pierce) was added to the cell lysates to precipitate the biotinylated proteins, which were electrophoresed on a 7% SDS-polyacrylamide gel and immunodetected.
ApoA-I binding⎯Cells grown on collagen-coated coverslips were incubated with DMEM containing 0.02% BSA and Alexa 546−conjugated apoA-I (5 μg/ml) for 15 min at 37°C. The cells were then washed, fixed with 4% paraformaldehyde at room temperature for 30 min, and observed with a confocal microscope (LSM 510; Carl Zeiss). washing procedure was repeated. The pellets were resuspended in lysis buffer B (20 mM Tris-Cl (pH 7.5), 1% Triton X-100, 0.1% SDS, and 1% sodium deoxycholate), and ABCA1 was immunoprecipitated with KM3110. The samples were electrophoresed on 7% SDS-polyacrylamide gels and then analyzed by autoradiography. The same membranes were analyzed by Western blotting with the indicated antibodies.
Anti-HA or anti-Flag antibody staining⎯Cells
Nucleotide trapping⎯Membrane fractions were prepared from HEK293 cells that were stably or transiently expressing ABCA1-GFP. The membrane fractions were incubated with 5 Statistical analysis⎯Values are presented as the means ± S.D. The statistical significance of differences between the mean values was analyzed using the non-paired t-test. Multiple comparisons were performed using Dunnett's test following ANOVA. A p-value < 0.05 was considered statistically significant.
Results

ApoA-I binding to ABCA1 is ATP-dependent⎯To characterize the interaction between
apoA-I and ABCA1-expressing cells, the effects of depleting cellular ATP were examined.
When Alexa 546−labeled apoA-I was added to the medium, apoA-I bound to ABCA1-expressing HEK293 cells within 10 min but not to the parental HEK293 cells, as previously reported (24, 28) ( Fig. 2A) . When the intracellular ATP levels were reduced by incubating the cells with sodium azide and 2-deoxy-D-glucose for 10 min, apoA-I binding was abolished, although ABCA1 expression on the plasma membrane was not affected (Fig. 2B ). Incubating the cells in glucose-containing medium for 10 min after ATP depletion restored apoA-I binding to comparable levels as before ATP depletion (Fig. 2B) . These results suggest that apoA-I binding is ABCA1-and ATP-dependent. The apoA-I on the cell surface may include both the direct binding to ABCA1 and the secondary association of lipidated apoA-I to the cell surface.
Two intact NBDs are required for apoA-I binding and cholesterol efflux⎯The contribution of the two NBDs of ABCA1 to apoA-I binding and cholesterol efflux by ABCA1 was analyzed.
Wild-type ABCA1 mediated apoA-I−dependent cholesterol efflux. However, cholesterol efflux was impaired in cells expressing ABCA1-K939M,K1952M, a mutant in which the Walker A lysines in both NBDs are replaced with methionines, or the single Walker A lysine mutants ABCA1-K939M or -K1952M, in which the Walker A lysine in NBD1 or NBD2 is replaced with methionine ( Fig. 3B) . Furthermore, these mutations did not significantly affect the expression levels ( Fig. 3A) and at least a fraction of the mutants were expressed on the plasma membrane (Fig. 3C ). ApoA-I binding was also impaired when either Walker A lysine was replaced with methionine ( Fig. 3C ). These results suggest that the two intact NBDs are required for apoA-I binding and apoA-I−dependent cholesterol efflux by ABCA1.
A Walker A lysine mutation abolishes ATP hydrolysis but not ATP binding⎯It has been reported that the two NBDs in some ABC proteins do not have equivalent roles in the ATP hydrolysis cycle and substrate transport (29) (30) (31) (32) . To analyze how the two NBDs of ABCA1 interact with ATP and how they are involved in the functions of ABCA1, the effects of Walker A lysine mutations in each NBD on ATP binding were examined (Fig. 4A) Therefore, we developed a new strategy to separate the two NBDs of ABCA1. First, Edman sequencing showed that the trypsin cleavage site in the linker region (B site) was after R1272 and R1273 ( Supplementary Fig. 1 ). To cleave ABCA1 specifically at this site, a TEV protease recognition sequence (ENLYFQG; TEV protease cleaves between Q and G) was introduced between R1272 and R1273 ( Fig. 2 ). The HA tag was inserted into nine sites within ABCA1-GFP, five in ECD1 and four in ECD2 (Fig. 1) . Six HA-insertion mutants (136HA, 207HA, 349HA, 443HA, 1421HA and 1490HA) were correctly expressed at the plasma membrane and mediated apoA-I binding similar to wild-type ABCA1-GFP (Fig. 7A) . However, three HA-insertion mutants (568HA, 1567HA and 1622HA) only minimally localized to the plasma membrane and did not mediate apoA-I binding, probably due to folding defects.
To examine the accessibility of the anti-HA antibody, HEK293 cells expressing the HA-insertion mutants were incubated with the anti-HA antibody at 37°C for 15 min in DMEM containing 0.02% BSA, and then cells were fixed and stained with an Alexa 546−conjugated secondary antibody (Fig. 7B) . Five HA-insertion mutants (136HA, 207HA, 349HA, 443HA and 1421HA) on the plasma membrane reacted with the anti-HA antibody. Interestingly, the 1490HA mutant did not react with the antibody, although it was correctly expressed at the plasma membrane and mediated apoA-I binding. It is likely that the epitope (1490) is conformationally inaccessible. Three HA-insertion mutants (568HA, 1567HA and 1622HA), which only minimally localized to the plasma membrane, were not stained with the anti-HA antibody.
ATP-dependent conformational changes in the ECDs⎯To analyze ATP-dependent
conformational changes in ABCA1, the accessibility of the anti-HA antibody to the HA tag in six mutants was examined after cellular ATP depletion (Fig. 8) . The intensity of the HA staining of the 443HA mutant was significantly decreased upon ATP depletion, while staining of the other five mutants (136HA, 207HA, 349HA, 1421HA, and 1490HA) was not affected. These results suggest that the accessibility of the anti-HA antibody to the HA tag at 443 is specifically altered by ATP depletion.
To determine the contribution of the two NBDs to the conformational changes in the ECDs, Walker A lysine mutations were introduced into the 443HA mutant and then the mutants were examined for anti-HA antibody accessibility. Replacing the Walker A lysine residue in either NBD of ABCA1-443HA significantly decreased the intensity of HA staining (Fig. 9C, D ) and abolished apoA-I binding (Fig. 10A) , while cell surface expression or the reactivity with the anti-HA antibody in Western blotting was not affected (Fig. 10C, D) . However, the mutation in ABCA1-207HA did not affect HA staining (Fig. 9A, B) . When FLAG tag was inserted into the position 443, replacing both Walker A lysine residues significantly decreased the staining with the anti-FLAG antibody also (Fig. 9E, F) , suggesting that the decrease in antibody staining did not merely reflect the change in reactivity of the epitope against the antibody. Because the 443HA and 443Flag mutants showed the ATP-dependent apoA-I binding (Fig. 10A ) and apoA-I-dependent cholesterol efflux (Fig. 10B) , the insertion of HA or Flag tag into the position changes of the 443HA and 443Flag mutants during the function are predicted to be same with those of the wild-type ABCA1. Together, these results suggest that ATP hydrolysis at both
NBDs induces conformational changes in the ECDs, which alters antibody accessibility to the region around 443, and that these conformational changes are associated with apoA-I binding.
Discussion
The first step in HDL generation is the binding of apoA-I to the plasma membrane of cells.
This step requires ABCA1 that is expressed on the plasma membrane. ABCA1 is induced by the nuclear receptor LXR that is activated by oxysterols, which are metabolites of excess cholesterol.
Because ABCA1 is a member of the ABC protein family, many of which mediate xenobiotic efflux and lipid transport in an ATP-dependent manner, it has been proposed that membrane phospholipid translocation via ABCA1 generates specific membrane domains that are bound by apoA-I (8, (14) (15) (16) . In this study, we examined the contribution of the two NBDs to ABCA1 function. 
